LAT2 and familial pancreatic carcinoma: To demonstrate the role of LAT2 in gemcitabine sensitivity in pancreatic cancer, we carried out growth inhibition assays to test the chemosensitivity of pancreatic cancer cells to gemcitabine in vitro and in vivo.